Literature DB >> 10821046

In vivo studies on the anti-inflammatory activity of pachymic and dehydrotumulosic acids.

E M Giner1, S Máñez, M C Recio, R M Giner, M Cerdá-Nicolás, J L Ríos.   

Abstract

Pachymic and dehydrotumulosic acids were studied in different models of acute and chronic inflammation. They proved to be active in most of the methods applied. None of them were active against arachidonic acid-induced ear edema. Dehydrotumulosic acid significantly diminished the mouse ear edema induced by ethyl phenylpropiolate, while pachymic acid was ineffective. When the putative corticoid-like mechanism of both compounds was explored, pachymic acid activity was partially abolished by the glucocorticoid receptor antagonist progesterone, but dehydrotumulosic acid activity was not affected. In vivo experiments demonstrated the inhibition by both principles of the phospholipase A2 (PLA2)-induced extravasation. The previous report on the effects of both compounds in vitro against PLA2, together with the present in vivo results, support the idea that the inhibition of this enzyme probably constitutes their main mechanism of action.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10821046     DOI: 10.1055/s-2000-8563

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  7 in total

1.  Pachymic Acid Enhances Pentobarbital-Induced Sleeping Behaviors via GABAA-ergic Systems in Mice.

Authors:  Vikash Kumar Shah; Jae Joon Choi; Jin-Yi Han; Mi Kyeong Lee; Jin Tae Hong; Ki-Wan Oh
Journal:  Biomol Ther (Seoul)       Date:  2014-07       Impact factor: 4.634

2.  A Comprehensive and Comparative Study of Wolfiporia extensa Cultivation Regions by Fourier Transform Infrared Spectroscopy and Ultra-Fast Liquid Chromatography.

Authors:  Yan Li; Ji Zhang; Tao Li; Honggao Liu; Yuanzhong Wang
Journal:  PLoS One       Date:  2016-12-30       Impact factor: 3.240

3.  The inhibition of Mpro, the primary protease of COVID-19, by Poria cocos and its active compounds: a network pharmacology and molecular docking study.

Authors:  Zhimin Wu; Xiaoxue Chen; Weiju Ni; Danshui Zhou; Shanshan Chai; Weile Ye; Zhengpu Zhang; Yuanqiang Guo; Liping Ren; Yu Zeng
Journal:  RSC Adv       Date:  2021-03-25       Impact factor: 3.361

Review 4.  Pharmacological profiles and therapeutic applications of pachymic acid (Review).

Authors:  Chunyong Wei; Hezhen Wang; Xun Sun; Zhixun Bai; Jing Wang; Guohui Bai; Qizheng Yao; Yingshu Xu; Lei Zhang
Journal:  Exp Ther Med       Date:  2022-07-01       Impact factor: 2.751

5.  Poria cocos Extract from Mushrooms Stimulates Aquaporin-3 via the PI3K/Akt/mTOR Signaling Pathway.

Authors:  Sung-Gu Park; Il-Joo Jo; Seol-A Park; Min-Cheol Park; Yeun-Ja Mun
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-09-15

6.  Meta-Analysis on the Chinese Herbal Formula Xiaoer-Feike Granules as a Complementary Therapy for Children With Acute Lower Respiratory Infections.

Authors:  Qiang You; Lan Li; Dan Li; Dan Yang; Lin Chen; Hong-Ping Chen; You-Ping Liu
Journal:  Front Pharmacol       Date:  2020-10-22       Impact factor: 5.810

7.  Anti-Inflammatory Activity of Four Triterpenoids Isolated from Poriae Cutis.

Authors:  Lijia Zhang; Mengzhou Yin; Xi Feng; Salam A Ibrahim; Ying Liu; Wen Huang
Journal:  Foods       Date:  2021-12-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.